Refining Precision Decisions in NSCLC With Common and Less Common EGFR Mutations: Navigating Testing and Treatment Throughout the Disease Continuum

Chair and Presenter, Natasha B. Leighl, MD, MMSc, FRCPC, FASCO, Joshua Sabari, MD, and Alexander I. Spira, MD, PhD, FACP, discuss NSCLC in this CME/MOC activity titled “Refining Precision Decisions in NSCLC With Common and Less Common EGFR Mutations: Navigating Testing and Treatment Throughout the Disease Continuum.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3FVwM0x. CME/MOC credit will be available until March 22, 2024.